On-demand posters

Check out the latest data on patient-derived organoids that HUB presented at ELRIG drug discovery meeting in 2022

Patient-derived organoids to predict clinical response: a patient in the lab^®

Development of a medium-to-high throughput organoid and bacteria co-culture platform for the assessment of host-pathogen interaction

Developing a patient-derived organoid biobank, suitable for large-scale drug screenings

Autologous organoids and T cell co-cultures as a powerful personalized platform for immunotherapy development

Patient-derived organoids as a relevant tool for preclinical IBD research and drug development